Jason Belzer retweeted
NYEVS is only 7 wks away, register at nyevs.org/
NYEVS is a multidisciplinary conference focused on the diagnosis and treatment of Peripheral Vascular Disease.
#endovascular #cardiology #peripheral #PAD #interventionalcardiology #aortic #cardiox #cardiotwitter
Jason Belzer retweeted
Diamondback 360 Precision™ is here!
With an enhanced drive shaft and GlideAssist™ mode, there's no need to ask, our new orbital #Atherectomy system is a 🎶smooth operator🎶.
Check it out, #CardioTwitter: bit.ly/3spNQIa
Safety Info: bit.ly/47W9HFU
Jason Belzer retweeted
Thrilled to join @AbbottCardio as the Chief Medical Officer for Vascular. The space is more exciting than ever, and Abbott is on the leading edge of innovation.
Thankful for 15yrs at @ProvHealth with extraordinary colleagues. So much good to come!
#AbbottProud #CardioTwitter
Jason Belzer retweeted
📣Big News! Our first-of-its-kind #TriClip G4 TEER system that’s specifically designed for treatment of tricuspid regurgitation has received FDA approval!
Read the press release: abbo.tt/TriClip_PR
Safety Info: abbo.tt/TriClip_ISI
#TricuspidRegurgitation #TEER
Jason Belzer retweeted
Don’t miss it! Abbott Endomasters in Miami! Join @PK_MountSinai @SriniTummala @mcbunte @artleemd , Alfio Carroccio for PAD/CLTI talks, live case, pedal loop, DVA and some sun and surf on the side! @SIRspecialists @ACCinTouch @VascularSVS @EndovascularNy web.cvent.com/event/cde6b589…
Jason Belzer retweeted
How can AI-enabled Ultreon Software help teach how to use #OCTimaging? In this video, Dr. Croce shares his thoughts based on his experience with the software.
Learn more: Ultreon.com
#imagefirst #cardiotwitter
Important Safety Info: bit.ly/ISI_info
Jason Belzer retweeted
Find us at #AFS2024 in Booth 403 to learn how you can achieve immediate and durable #Hemostasis with our #Perclose Prostyle SMCR System.¹
Discover the benefits of adding this device to your EP workflows: bit.ly/415VODd
Safety Info: bit.ly/47SRjhX
Jason Belzer retweeted
At #TCT2023, @sahilparikhmd, @RamonVarcoeMD, @EricSecemskyMD, @Kandzari, and Dominick Angiolillo discuss the efficacy and safety of Esprit BTK for the treatment of CLTI.
tctmd.com/news/life-btk-bior…
Jason Belzer retweeted
In the U.S. alone, peripheral artery disease affects over 8 million people. That’s why we’re working on groundbreaking treatment options to help treat blocked arteries.
Check out the latest data from LIFE-BTK: abbo.tt/45KrVsO
Jason Belzer retweeted
Is improving the PAD #PatientExperience palpable, or a pipedream?
Don’t miss our expert panel at @OEISociety to dig deep into our latest research on the biggest challenges impacting the #Vascular patient journey and how we might overcome them: https://teapaw.org/t.co/adrwDLTxuJ
Jason Belzer retweeted
74 yo w non healing wound of several months duration. Long segment cto with no vein. Antegrade and retrograde via the pt, through and through wire access with eventual supera placement. Now wound healed on 3 month follow up.
Jason Belzer retweeted
Join us on June 5 at 10a.m. ET for our latest highly interactive, case-based EndoMasters #MedEd session, featuring complex cases on #CTLI and more. Distinguished faculty includes @PK_MountSinai, @SriniTummala, and @VascularMD.
Register now to participate: https://teapaw.org/t.co/hv2Iwu0AmV
Jason Belzer retweeted
Please share this survey with your cath lab nurses/techs! We are looking at the impact of #COVID19 in hope to support nurses/techs moving forward. @Tesslagra @CathLabDigest @Mustapja @CarlaMa87968905 @drsavealimb @AmputationSuck @HadyLichaaMD @DrAmirKaki surveymonkey.com/r/MVCRMCM
Jason Belzer retweeted
Pt facing amputation. Non flow limiting dissection on fluoro p PTA. IVUS showed dissections. Final fix w stents. @drsavealimb @ifarooqMD @Mustapja @kmadass @EVToday @shishem @OchsnerCardio @jmills1955 @t_intheleadcoat @SriniTummala @Aashish70228729
Jason Belzer retweeted
Come to our booth at #TCT2019 to get hands-on deployment experience with suture-mediated closure using #Perclose ProGlide.
Learn more: AbbottatTCT.com
Important safety info: https://teapaw.org/t.co/hjTo9J0BzX
Jason Belzer retweeted
In this @EJVES_ESVS study we show that @AbbottNews Supera & DESs (e.g. @cookvascular ZPTX or @bostonsci Eluvia) in the fem-pop segment have similar patency at 2 years, regardless of plaque Ca2+ @DrKKatsanos @EndovascularU @Vascupedia_com @VascularNews
ejves.com/article/S1078-5884…
Jason Belzer retweeted
65 DM CKD CLI recan P2/P3, TP Trunk, Peroneal Art etc. Non flow limiting Pop Art Dissection. Prolonged PTA no change. Would you stent? If yes then what stent? @ACCinTouch @VascularSVS @SIRspecialists @Mustapja @FadiSaab17 @kmadass @SDhandMD @Watts_IR @NCVHonline @VIVAPhysicians
Jason Belzer retweeted
Live #FROMACV second live case #AssitedTAMI, CTO crossing and Supera deployment retrograde via pedal access @AMPSymposium @kmadass @Mustapja @drsavealimb @TimYatesMD @baileyannRN @Watts_IR @SDhandMD @AvaStarMD @belzerj @abbottvascular – at Grand Rapids, MI
Jason Belzer retweeted
Siked about #LINCMtSinai2019, grateful to be faculty and part of the expert exchange. Also the concentrated stare and tie. @MountSinaiMiami @SinaiVascular @MountSinaiIR @MountSinaiNYC @CLI_Global @CLIfighters #CLIfighters @belzerj @SIRRFS @SIRspecialists






























